Insider

Reshma Kewalramani

CEO & President · Vertex Pharmaceuticals Inc / MA (VRTX)

sold: $6,307,135

DateTradeSharesAvg. priceValueFiling
November 6, 2026Sale 10b5-1 plan notice filed11,866$531.53$6,307,135SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.